Profit Or Loss [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profit or loss [abstract] | ||||||||||
| Profit (loss) [abstract] | ||||||||||
| Raw materials and consumables used | — | — | — |
26,000
BGN
|
— | — | — |
31,000
BGN
|
— | — |
| Employee benefits expense | — | — | — |
224,000
BGN
|
— | — | — |
229,000
BGN
|
— | — |
| Depreciation and amortisation expense | — | — | — |
13,000
BGN
|
— | — | — |
14,000
BGN
|
— | — |
| Other expenses, by nature | — | — | — |
7,000
BGN
|
— | — | — |
9,000
BGN
|
— | — |
| Profit (loss) from operating activities | — | — | — |
339,000
BGN
|
— | — | — |
74,000
BGN
|
— | — |
| Finance income | — | — | — |
227,000
BGN
|
— | — | — |
229,000
BGN
|
— | — |
| Finance costs | — | — | — |
120,000
BGN
|
— | — | — |
122,000
BGN
|
— | — |
| Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9 | — | — | — |
73,000
BGN
|
— | — | — |
307,000
BGN
|
— | — |
| Profit (loss) before tax | — | — | — |
446,000
BGN
|
— | — | — |
33,000
BGN
|
— | — |
| Tax expense (income) | — | — | — |
44,000
BGN
|
— | — | — |
0
BGN
|
— | — |
| Profit (loss) |
1,000
BGN
|
0
BGN
|
0
BGN
|
402,000
BGN
|
403,000
BGN
|
33,000
BGN
|
0
BGN
|
33,000
BGN
|
0
BGN
|
0
BGN
|